This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laing, F. P.
Right arrow Articles by Louie, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laing, F. P.
Right arrow Articles by Louie, T. J.

Next Article 

Journal of Clinical Microbiology, 03 1995, 513-518, Vol 33, No. 3
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Molecular epidemiology of Xanthomonas maltophilia colonization and infection in the hospital environment

FP Laing, K Ramotar, RR Read, N Alfieri, A Kureishi, EA Henderson and TJ Louie
Faculty of Medicine, University of Calgary, Alberta, Canada.

Between April 1992 and December 1993, 80 Xanthomonas maltophilia isolates were collected from 63 patients in three acute-care hospitals in Calgary, Alberta, Canada. On the basis of Centers for Disease Control and Prevention definitions, 48 patients had nosocomial and 15 had community-acquired X. maltophilia. Thirty-eight of the patients were colonized and 25 were infected. Sixty-four percent of patients who acquired X. maltophilia in the intensive care unit (ICU) became infected, whereas 32% of patients in a non-ICU setting became infected. ICU patients tended to be hospitalized for a shorter period of time than non-ICU patients before the onset of X. maltophilia infection. Regardless of being colonized or infected, all patients had debilitating conditions, with respiratory disease being the most common underlying illness (35%). Forty-two patients (88%) with hospital- acquired X. maltophilia received prior antibiotic therapy which included gentamicin, tobramycin, ceftazidime, piperacillin, and imipenem. Agar dilution MICs showed that patient isolates were resistant to these antimicrobial agents that patients had received. Pulsed-field gel electrophoresis of SpeI-digested genomic DNA revealed that six epidemiologically linked patient isolates from the ICU of one acute-care hospital had identical DNA profiles. In contrast, isolates from patients from the other two hospitals had unique genotype profiles (n = 57) regardless of the presence or absence of an epidemiologic association. In these patients there was genetic evidence against the acquisition of a resident hospital clone. These results indicate that pulsed-field gel electrophoresis can resolve genotypically distinct strains of X. maltophilia and, consequently, is a useful tool for evaluating nosocomial infections caused by X. maltophilia.


This article has been cited by other articles:

  • Denis, M. St., Ramotar, K., Vandemheen, K., Tullis, E., Ferris, W., Chan, F., Lee, C., Slinger, R., Aaron, S. D. (2007). Infection With Burkholderia cepacia Complex Bacteria and Pulmonary Exacerbations of Cystic Fibrosis. Chest 131: 1188-1196 [Abstract] [Full Text]  
  • Singh, A., Goering, R. V., Simjee, S., Foley, S. L., Zervos, M. J. (2006). Application of Molecular Techniques to the Study of Hospital Infection. Clin. Microbiol. Rev. 19: 512-530 [Abstract] [Full Text]  
  • DeShazer, D. (2004). Genomic Diversity of Burkholderia pseudomallei Clinical Isolates: Subtractive Hybridization Reveals a Burkholderia mallei-Specific Prophage in B. pseudomallei 1026b. J. Bacteriol. 186: 3938-3950 [Abstract] [Full Text]  
  • Aaron, S. D., Ramotar, K., Ferris, W., Vandemheen, K., Saginur, R., Tullis, E., Haase, D., Kottachchi, D., St. Denis, M., Chan, F. (2004). Adult Cystic Fibrosis Exacerbations and New Strains of Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med. 169: 811-815 [Abstract] [Full Text]  
  • Barbolla, R., Catalano, M., Orman, B. E., Famiglietti, A., Vay, C., Smayevsky, J., Centron, D., Pineiro, S. A. (2004). Class 1 Integrons Increase Trimethoprim-Sulfamethoxazole MICs against Epidemiologically Unrelated Stenotrophomonas maltophilia Isolates. Antimicrob. Agents Chemother. 48: 666-669 [Abstract] [Full Text]  
  • Valdezate, S., Vindel, A., Martin-Davila, P., Del Saz, B. S., Baquero, F., Canton, R. (2004). High Genetic Diversity among Stenotrophomonas maltophilia Strains Despite Their Originating at a Single Hospital. J. Clin. Microbiol. 42: 693-699 [Abstract] [Full Text]  
  • Aaron, S. D., Ferris, W., Ramotar, K., Vandemheen, K., Chan, F., Saginur, R. (2002). Single and Combination Antibiotic Susceptibilities of Planktonic, Adherent, and Biofilm-Grown Pseudomonas aeruginosa Isolates Cultured from Sputa of Adults with Cystic Fibrosis. J. Clin. Microbiol. 40: 4172-4179 [Abstract] [Full Text]  
  • Woods, D. E., Jeddeloh, J. A., Fritz, D. L., DeShazer, D. (2002). Burkholderia thailandensis E125 Harbors a Temperate Bacteriophage Specific for Burkholderia mallei. J. Bacteriol. 184: 4003-4017 [Abstract] [Full Text]  
  • Krzewinski, J. W., Nguyen, C. D., Foster, J. M., Burns, J. L. (2001). Use of Random Amplified Polymorphic DNA PCR To Examine Epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from Patients with Cystic Fibrosis. J. Clin. Microbiol. 39: 3597-3602 [Abstract] [Full Text]  
  • Berg, G., Roskot, N., Smalla, K. (1999). Genotypic and Phenotypic Relationships between Clinical and Environmental Isolates of Stenotrophomonas maltophilia. J. Clin. Microbiol. 37: 3594-3600 [Abstract] [Full Text]  
  • Denton, M., Todd, N. J., Kerr, K. G., Hawkey, P. M., Littlewood, J. M. (1998). Molecular Epidemiology of Stenotrophomonas maltophilia Isolated from Clinical Specimens from Patients with Cystic Fibrosis and Associated Environmental Samples. J. Clin. Microbiol. 36: 1953-1958 [Abstract] [Full Text]  
  • Denton, M., Kerr, K. G. (1998). Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia. Clin. Microbiol. Rev. 11: 57-80 [Abstract] [Full Text]  
  • Penland, R. L., Wilhelmus, K. R. (1996). Stenotrophomonas maltophilia Ocular Infections. Arch Ophthalmol 114: 433-436 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»